Infant Study of Inhaled Saline in Cystic Fibrosis
NCT00709280
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
321
Enrollment
NETWORK
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
7% Hypertonic Saline (HS)
DRUG:
0.9% Isotonic Saline (IS)
Sponsor
CF Therapeutics Development Network Coordinating Center
Collaborators
[object Object]
[object Object]